Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Viomedex Limited currently has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. Both of these actions are assigned to 1 distinct examiner, creating a high level of examiner concentration for the portfolio. These matters are also located within 1 distinct art unit, further centralizing the prosecution process. This total concentration under 1 distinct examiner and 1 distinct art unit means that the company's current legal strategy is entirely dependent on a single individual's review within a specific technical group.
DIXON, ANNETTE FREDRICKA is the busiest examiner for the company, managing 2 busiest examiner pending actions. Since there are 2 pending office actions in total and only 1 distinct examiner, this examiner is responsible for the entirety of the company's current pending workload. This concentration in 1 distinct art unit and under 1 distinct examiner means that the outcome of both actions depends on the same individual's interpretation of medical device and mechanical engineering standards. For the practitioner, this means that success or failure in 1 action is highly likely to correlate with the other. The 2 busiest examiner pending actions represent the full scope of the company's current interaction with the USPTO, requiring a focused approach to satisfy the specific requirements of DIXON, ANNETTE FREDRICKA.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DIXON, ANNETTE FREDRICKA | 2 | 74.3% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18594571 | THERAPY DELIVERY DEVICE | DIXON, ANNETTE FREDRICKA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18594571 | THERAPY DELIVERY DEVICE | DIXON, ANNETTE FREDRICKA | — |
| 18594596 | THERAPY DELIVERY DEVICE | DIXON, ANNETTE FREDRICKA | — |
| Art Unit | Apps |
|---|---|
| 3785 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18594571 | THERAPY DELIVERY DEVICE | DIXON, ANNETTE FREDRICKA | 3785 | §102§103 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18594596 | THERAPY DELIVERY DEVICE | DIXON, ANNETTE FREDRICKA | 3785 | §102 | Non-Final OA | — | Pending | Mar 04, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialViomedex Limited has 2 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Annette Fredricka Dixon has the most, with 2 of Viomedex Limited's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
